Assessment of cervical cancer screening policy in Korea for women over age 65

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: The purpose of this study was to evaluate the efficacy of cervical cancer screening (CCS) in Korean women over 65. years of age and to determine the age at which CCS becomes inefficacious, so that providers and policy makers can be more informed about when to stop screening. Materials and Methods: The data of 999 women, who underwent CCS followed by colposcopy at the Korea University hospital from January 2007 to May 2012, were retrospectively evaluated. Age groups were classified as <. 21 (n. =. 11), 21-29 (n. =. 128), 30-65 (n. =. 768), and >. 65 (n. =. 92). To evaluate the value of CCS in women older than 65, age groups were simply divided into ≤. 65 or >. 65. Participants were also categorized into five strata of age groups (≤. 55 vs. >. 55, ≤. 60 vs. >. 60, ≤. 65 vs. >. 65, ≤. 70 vs. >. 70, and ≤. 75 vs. >. 75) that were compared to the sample to assess a cutoff-age at which to cease screening based on decreased efficacy. Results: The mean age was 45.5. ±. 13.7 (range14-80). There were no differences in the pathologic results for cervical intraepithelial neoplasia (CIN) values of <. CIN2 vs. ≥. CIN2, or ≤. CIN3 vs. cancer among the groups. There was a significantly higher incidence of cancer compared with ≤. CIN3 in women aged >. 65 (13.0%) vs. ≤. 65 (6.6%), (p. =. 0.037). To assess the cervical cancer incidence (CCI) from the larger number of cases by age, a prediction formula was calculated from a national dataset. CCI (per 100,000) continuously increased by age even for those in their 90s. Conclusion: CCS is still necessary in Korean women older than 65 since there is a substantial CCI rate occurring in these women. It is time to consider new guidelines that include the appropriate age and conditions for discontinuing screening.

Original languageEnglish
Pages (from-to)382-387
Number of pages6
JournalJournal of Geriatric Oncology
Volume4
Issue number4
DOIs
Publication statusPublished - 2013 Oct 1

Fingerprint

Korea
Early Detection of Cancer
Uterine Cervical Neoplasms
Age Groups
Incidence
Colposcopy
Cervical Intraepithelial Neoplasia
Administrative Personnel
Guidelines

Keywords

  • Age
  • Cervical cancer
  • Guideline
  • Policy
  • Screening

ASJC Scopus subject areas

  • Oncology
  • Geriatrics and Gerontology

Cite this

@article{6b2172db5a2f48fea3c3185ea39aaa6c,
title = "Assessment of cervical cancer screening policy in Korea for women over age 65",
abstract = "Objectives: The purpose of this study was to evaluate the efficacy of cervical cancer screening (CCS) in Korean women over 65. years of age and to determine the age at which CCS becomes inefficacious, so that providers and policy makers can be more informed about when to stop screening. Materials and Methods: The data of 999 women, who underwent CCS followed by colposcopy at the Korea University hospital from January 2007 to May 2012, were retrospectively evaluated. Age groups were classified as <. 21 (n. =. 11), 21-29 (n. =. 128), 30-65 (n. =. 768), and >. 65 (n. =. 92). To evaluate the value of CCS in women older than 65, age groups were simply divided into ≤. 65 or >. 65. Participants were also categorized into five strata of age groups (≤. 55 vs. >. 55, ≤. 60 vs. >. 60, ≤. 65 vs. >. 65, ≤. 70 vs. >. 70, and ≤. 75 vs. >. 75) that were compared to the sample to assess a cutoff-age at which to cease screening based on decreased efficacy. Results: The mean age was 45.5. ±. 13.7 (range14-80). There were no differences in the pathologic results for cervical intraepithelial neoplasia (CIN) values of <. CIN2 vs. ≥. CIN2, or ≤. CIN3 vs. cancer among the groups. There was a significantly higher incidence of cancer compared with ≤. CIN3 in women aged >. 65 (13.0{\%}) vs. ≤. 65 (6.6{\%}), (p. =. 0.037). To assess the cervical cancer incidence (CCI) from the larger number of cases by age, a prediction formula was calculated from a national dataset. CCI (per 100,000) continuously increased by age even for those in their 90s. Conclusion: CCS is still necessary in Korean women older than 65 since there is a substantial CCI rate occurring in these women. It is time to consider new guidelines that include the appropriate age and conditions for discontinuing screening.",
keywords = "Age, Cervical cancer, Guideline, Policy, Screening",
author = "Sanghoon Lee and Hyun-Tae Park and Jin-Hwa Hong and Song, {Jae Yun} and Lee, {Jae Kwan} and Lee, {Nak Woo} and Tak Kim and Lee, {Kyu Wan}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.jgo.2013.03.001",
language = "English",
volume = "4",
pages = "382--387",
journal = "Journal of Geriatric Oncology",
issn = "1879-4068",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Assessment of cervical cancer screening policy in Korea for women over age 65

AU - Lee, Sanghoon

AU - Park, Hyun-Tae

AU - Hong, Jin-Hwa

AU - Song, Jae Yun

AU - Lee, Jae Kwan

AU - Lee, Nak Woo

AU - Kim, Tak

AU - Lee, Kyu Wan

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Objectives: The purpose of this study was to evaluate the efficacy of cervical cancer screening (CCS) in Korean women over 65. years of age and to determine the age at which CCS becomes inefficacious, so that providers and policy makers can be more informed about when to stop screening. Materials and Methods: The data of 999 women, who underwent CCS followed by colposcopy at the Korea University hospital from January 2007 to May 2012, were retrospectively evaluated. Age groups were classified as <. 21 (n. =. 11), 21-29 (n. =. 128), 30-65 (n. =. 768), and >. 65 (n. =. 92). To evaluate the value of CCS in women older than 65, age groups were simply divided into ≤. 65 or >. 65. Participants were also categorized into five strata of age groups (≤. 55 vs. >. 55, ≤. 60 vs. >. 60, ≤. 65 vs. >. 65, ≤. 70 vs. >. 70, and ≤. 75 vs. >. 75) that were compared to the sample to assess a cutoff-age at which to cease screening based on decreased efficacy. Results: The mean age was 45.5. ±. 13.7 (range14-80). There were no differences in the pathologic results for cervical intraepithelial neoplasia (CIN) values of <. CIN2 vs. ≥. CIN2, or ≤. CIN3 vs. cancer among the groups. There was a significantly higher incidence of cancer compared with ≤. CIN3 in women aged >. 65 (13.0%) vs. ≤. 65 (6.6%), (p. =. 0.037). To assess the cervical cancer incidence (CCI) from the larger number of cases by age, a prediction formula was calculated from a national dataset. CCI (per 100,000) continuously increased by age even for those in their 90s. Conclusion: CCS is still necessary in Korean women older than 65 since there is a substantial CCI rate occurring in these women. It is time to consider new guidelines that include the appropriate age and conditions for discontinuing screening.

AB - Objectives: The purpose of this study was to evaluate the efficacy of cervical cancer screening (CCS) in Korean women over 65. years of age and to determine the age at which CCS becomes inefficacious, so that providers and policy makers can be more informed about when to stop screening. Materials and Methods: The data of 999 women, who underwent CCS followed by colposcopy at the Korea University hospital from January 2007 to May 2012, were retrospectively evaluated. Age groups were classified as <. 21 (n. =. 11), 21-29 (n. =. 128), 30-65 (n. =. 768), and >. 65 (n. =. 92). To evaluate the value of CCS in women older than 65, age groups were simply divided into ≤. 65 or >. 65. Participants were also categorized into five strata of age groups (≤. 55 vs. >. 55, ≤. 60 vs. >. 60, ≤. 65 vs. >. 65, ≤. 70 vs. >. 70, and ≤. 75 vs. >. 75) that were compared to the sample to assess a cutoff-age at which to cease screening based on decreased efficacy. Results: The mean age was 45.5. ±. 13.7 (range14-80). There were no differences in the pathologic results for cervical intraepithelial neoplasia (CIN) values of <. CIN2 vs. ≥. CIN2, or ≤. CIN3 vs. cancer among the groups. There was a significantly higher incidence of cancer compared with ≤. CIN3 in women aged >. 65 (13.0%) vs. ≤. 65 (6.6%), (p. =. 0.037). To assess the cervical cancer incidence (CCI) from the larger number of cases by age, a prediction formula was calculated from a national dataset. CCI (per 100,000) continuously increased by age even for those in their 90s. Conclusion: CCS is still necessary in Korean women older than 65 since there is a substantial CCI rate occurring in these women. It is time to consider new guidelines that include the appropriate age and conditions for discontinuing screening.

KW - Age

KW - Cervical cancer

KW - Guideline

KW - Policy

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84884986237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884986237&partnerID=8YFLogxK

U2 - 10.1016/j.jgo.2013.03.001

DO - 10.1016/j.jgo.2013.03.001

M3 - Article

VL - 4

SP - 382

EP - 387

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

SN - 1879-4068

IS - 4

ER -